Viveve Medical, Inc. (VIVE)
- Previous Close
0.0003 - Open
0.0002 - Bid --
- Ask --
- Day's Range
0.0002 - 0.0002 - 52 Week Range
0.0001 - 0.1107 - Volume
11,527 - Avg. Volume
2,949 - Market Cap (intraday)
2,145 - Beta (5Y Monthly) 0.14
- PE Ratio (TTM)
-- - EPS (TTM)
-2.6500 - Earnings Date Apr 29, 2024 - May 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
www.viveve.comRelated News
Performance Overview: VIVE
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VIVE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VIVE
Valuation Measures
Market Cap
2.14k
Enterprise Value
-23.86k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.00
Price/Book (mrq)
0.00
Enterprise Value/Revenue
-0.00
Enterprise Value/EBITDA
0.00
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-62.13%
Return on Equity (ttm)
-210.99%
Revenue (ttm)
6.83M
Net Income Avi to Common (ttm)
-28.14M
Diluted EPS (ttm)
-2.6500
Balance Sheet and Cash Flow
Total Cash (mrq)
5.91M
Total Debt/Equity (mrq)
507.94%
Levered Free Cash Flow (ttm)
-7.58M